Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Erectile dysfunction

Erectile dysfunction drugs linked to decreased mortality after heart attack

Users of phosphodiesterase-5 inhibitors were found to have lower risk of death or rehospitalisation after heart attack.

Erectile dysfunction is associated with an increased risk of cardiovascular disease, but it is unknown what effect the condition has on outcomes following a heart attack.

To find out, researchers studied data on 43,145 men in Sweden aged under 80 years who were hospitalised for a first myocardial infarction.

Over a mean follow-up of 6.2 years, they found that the 7% of men who filed a prescription for an erectile dysfunction medication had a 33% reduced risk of mortality and 40% reduced risk of hospitalisation for heart failure. Further analysis showed that this reduction in mortality risk was only observed in users of phosphodiesterase-5 (PDE5) inhibitors and not alprostadil users.

Publishing their report in Heart[1] (online, 9 March 2017), the researchers say the findings should reassure doctors that they can prescribe PDE5 inhibitors to men after a heart attack, provided there are no contraindications.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202560

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Handbook of Drug Administration via Enteral Feeding Tubes

    Handbook of Drug Administration via Enteral Feeding Tubes

    All you need to know about prescribing or administering drugs via enteral feeding tubes. Over 400 drug monographs as well as facts to inform clinical decision making.

    £54.00Buy now
  • Prescribing Medicines for Children

    Prescribing Medicines for Children

    Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.

    £60.00Buy now
  • Drugs in Use

    Drugs in Use

    Optimise drug therapy for your patients. These case studies help you bridge the gap between theoretical medicines knowledge and practical applications.

    £43.00Buy now
  • Palliative Care Formulary (PCF6)

    Palliative Care Formulary (PCF6)

    Palliative Care Formulary is a comprehensive combination of independent information about drugs used in palliative care.

    £55.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Molecular structure of PDE5 inhibitor

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.